Valeant Pharma Fails To Reach $100 On Intraday Basis For The First Time Since September 2013

Valeant Pharma

shares are trading lower by $4.23 at $93.63 in Wednesday's session. Off the open, it failed to reach triple digits on an intraday basis for the first time since September 13, 2013, when it peaked at $99.50. Since making the high, it has declined to $92.29 and has not been about to mount much of a rally. There is one daily support level ahead of the low for the recent down move. That stands at its October 30 low ($90.46)

Do you like this article? Do you have suggestions for improvement? Please email feedback@benzinga.com.